Lenalidomide as maintenance therapy in patients with relapsed DLBCL not eligible for transplantation — Phase II final results

Andrés J.M. Ferreri and colleagues designed a phase II trial to evaluate...

Alexander study: CD19/22 dual targeting CAR T-cell therapy with pembrolizumab in R/R DLBCL

During the American Society of Clinical Oncology (ASCO) Annual Meeting, the Lymphoma Hub was delighted to...

Positive interim results announced for TRPH-222 in patients with NHL

On May 18, 2020, positive interim results were announced from the multi-center, open-label, phase I study of TRPH-222...

The FDA accepts supplemental new drug application for selinexor as a treatment for R/R DLBCL

On February 19, 2020, the U.S. Food and Drug Administration (FDA) accepted a supplemental new drug...

Brentuximab vedotin plus CHP is approved by the European Commission and China for the treatment of adult patients with sALCL

On May 14, 2020, brentuximab vedotin in combination with cyclophosphamide,...

Phase III study of omidubicel in patients with high-risk hematologic malignancies meets primary endpoint

Positive results from a phase III study of omidubicel, a cell therapy product of expanded...

AACR 2020 | Preliminary results of the EMBOLDEN and DURABILITY phase I studies on the combination of immune checkpoint inhibitors with epigenetic therapy in patients with T-cell lymphoma

At the...

AACR 2020 | The rationale of combining PD1 blockade with two epigenetic modifiers for T-cell lymphoma treatment

The Lymphoma Hub was pleased to speak with Enrica Marchi, Center for Lymphoid...

Positive interim results announced for TRPH-222 in patients with NHL

On May 18, 2020, positive interim results were announced from the multi-center, open-label, phase I study of TRPH-222...

NICE backs obinutuzumab plus bendamustine chemotherapy for patients with follicular lymphoma

The United Kingdom’s National Institute for Health and Clinical Excellence (NICE) has recommended the...

AACR 2020 | Ibrutinib plus rituximab as a first-line treatment for patients with follicular lymphoma

Nathan Fowler and colleagues investigated the efficacy and safety of rituximab in combination with...

Long term follow-up of chlorambucil, mitoxantrone and dexamethasone vs fludarabine, mitoxantrone and dexamethasone in patients with FL

Mark J. Bishton and colleagues compared chlorambucil,...